Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior-Reference-Cited by-同舟云学术

Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior

Published:2005-03-12 Issue:8 Volume:48 Page:2814-2821
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Pigeon Pascal¹,Top Siden¹,Vessières Anne¹,Huché, Michel¹,Hillard Elizabeth A.¹,Salomon Emmanuel¹,Jaouen Gérard¹

Affiliation:

1. Laboratoire de Chimie et Biochimie des Complexes Moléculaires, Ecole Nationale Supérieure de Chimie de Paris, UMR CNRS 7576, 11, rue Pierre et Marie Curie, 75231 Paris Cedex 05, France

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm049268h

Reference47 articles.

1. The Lifetime Risk of Developing Breast Cancer

2. Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program

3. Advances in the Science of Estrogen Receptor Modulation

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal applications of vanadium complexes with Schiff bases;Journal of Trace Elements in Medicine and Biology;2023-09

2. Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal–Drug Synergism in Metallodrug Design;Molecular Pharmaceutics;2023-02-20

3. Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer;Journal of Medicinal Chemistry;2023-02-13

4. In vivo testing of the anti-inflammatory action of topical formulations containing cobalt complexes with oxicams;Public Health and Toxicology;2023-01-16

5. Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses;Chemical Society Reviews;2023